Most emerging markets (EMs), including India, have experienced volatility ahead of Donald Trump's second term. However, ...

Teva cannot market its generic version of Firdapse in the U.S. before February 25, 2035, unless specific conditions arise. Ongoing Firdapse patent litigation continues against Hetero and Lupin ...

Despite weathering significant criticism from lawmakers and patient groups over the steep cost of its rare disease med ...

On Wednesday, Catalyst Pharmaceuticals Inc. (NASDAQ ... If approved by the FDA, Teva will not market its generic version of Firdapse in the United States before February 25, 2035, unless certain ...

It wasn't just fact-checking that Meta scrapped from its platforms as it prepares for the second Trump administration. Meta ...

The now-deleted sentence said that hate speech “creates an environment of intimidation and exclusion, and in some cases may promote ... not only in the United States where there has been an ...

Bezuclastinib's upcoming data in July 2025 could be a game-changer for COGT, offering a lucrative investment opportunity. See ...

We trust that is the case. The underlying message of the museum ... But if you’d told us on New Year’s Day that we’d be seeing some of the most beautiful neighborhoods in Los Angeles burn ...

Meta CEO Mark Zuckerberg said Tuesday that the company will “remove restrictions on topics like immigration and gender that are out of touch with mainstream discourse,” citing “recent elections” as a ...

BOSTON, MA / ACCESSWIRE / January 9, 2025 / MassRobotics announces the fourth cohort of its Healthcare Robotics Startup Catalyst Program ... in supporting their US market entry initiatives ...

Plus, European companies should prepare for activists and US banks confront whether they can underwrite blacklisted companies in Hong Kong ...